A Trial of ABSK043, an Oral PD-L1 Inhibitor, in Patients With Angiogenic Sarcomas
Clinical trial NCT07014137 · RECRUITING
Trial details
- NCT number
- NCT07014137
- Sponsor
- University Health Network, Toronto
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-09
- Primary completion
- 2027-03-02
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.